[1] SuzukiA, Miyagawa-Tomita S, Nakazawa M,et al. Remod?
eling of cononary arter lesions due to Kawasaki disease : com?
parison of arteriographic and immunohischemical findings[J].
Jpn Heart,2000,41(3):245-256.
[2] 王从军,陈梅,雷中劲.川崎病患儿细胞免疫功能状况及转录因
子T-bet和GATA3的调控作用[J].中国病理生理杂志,
2014,30(4):733-737.
[3] 韩云坤,孙冰,李丽红,等.川崎病T细胞免疫及细胞因子变化的
研究[J].中国实验诊断学,2014,15(9):1533-1536.
[4] Newburger JW, Takahashi M, Gerber MA,et al. Diagnosis,
treatment, and long-time management of Kawasaki disease:a
statement for health professionals from the Committee on
Rheumatic Fever, Endocarditis and Kawasaki disease,Council
on Cardiovascular disease in the Young, American Heart As?
sociation[J].Pediatrics,2004,114(6):1708-1733.
[5]Alexoudi I, Kanakis M, Kapsimali V,et al. Kawasaki disease:
Current aspects on aetiopath- ogenesis and therapeutic man?
agement[J].Autoimmun Rev,2011,10(9):544-547.
[6]Sakata K, Hamaoka K, Ozawa S,et a1. Matrix metallopro?
teinase-9in vascular lesions an d endothelial regulation in Ka?
wasakidiseasel[J].Circ J,2010,74(8):1670-1675.
[7]Cheng YC, Chen LM, Chang MH,et a1. Lipopolysaccharide
upregu-lates uPA, MMP-2and MMPO via ERK1/2signal?
ing in H9c2 cardiomyoblast cells[J].Mol Cel Bioehem,
2009,325(1-2):15-23.
[8]Lee TJ, Chun JK, Yeon SI,et a1. Increased serum levels of
macrophage migration inhibitory factor in patients with Kawa?
sakidisease[J].Scand jRheumatol,2007,36(3):222-225.
[9]Okada Y, Shinohara M, Kobayashi T,et a1. Effect of cortico?
steroids in addition to intravenous gam ma globulin therapy on
serum cyto—kine levels in the acute phase of Kawasaki disease
in children[J].J Pediatr,2003,143(3):363-367.
[10]SabatR, GrützG, Warszawskak,et al. Biology of interleukin-10 [J].Cytokine Growth Factor Rev, 2010,21(5) : 331-344.
[11]Maynard CL, Weaver CT. Diversity in the contribution of in?
terleukin-10to T- cell- mediated immune regulation [J].
ImmunolRev,2008,226:219-233.
[12]Veldhoen M, Uyttenhove C, vail Snick J,et al. Transforming
growth factor–beta 'reprograms' the differentiation of T helper
2cells and promotes an interleukin9-producing subset[J].
NatImmunol,2008,9(12):134l-1346.
[13]O'Garra A, Vieira P. T (H) l cells control themselves by pro?
ducing interleukin-10[J].Nature Rev lmmunol,2007,7
(6):425-428.
[14]Wolk K, Witte E, Witte K,et al. Biology of interleukin -22
[J].Semin Immunopathol,2010,32(1):17-31.
[15] Ryan JJ, Kashyap M, Bailey D,et al. Mast cell bomeostasis:a
fundamental aspect of allergic disease [J].Crit Rev Immu?
nol,2007,27(1):15-32.
[16] 孙飞,沈文娟,冯俊杰.川崎病急性期患儿血清IL-10水平的变
化[J].新医学,2010,41(10):664-665.
[17] 付劲蓉,李成荣,周玉峰,等.白细胞介素-10在川崎病炎性细胞
因子介导的血管损伤中的作用初探[J].中华风湿病学杂志,
2001,5(6):363-366.
[18] 张本山,郑敏翠,李婉丽,等.川崎病患儿IL-10和IL-18表达
水平对冠状动脉的影响[J].中国医药导刊,2012,14(5),861-862.